18705154

Source:http://linkedlifedata.com/resource/pubmed/id/18705154

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0041536, umls-concept:C0087111, umls-concept:C0456387, umls-concept:C1135191
pubmed:issue	3
pubmed:dateCreated	2008-8-15
pubmed:abstractText	Coenzyme Q10 (CoQ10) supplementation has been reported to improve symptoms of heart failure and quality of life, and to reduce hospitalisation. Most prior trials have been open-label and in some, only 50% of patients took angiotensin converting enzyme inhibitors (ACEI).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100963739
pubmed:status	PubMed-not-MEDLINE
pubmed:issn	1443-9506
pubmed:author	pubmed-author:AboyounChristinaC, pubmed-author:BaileyMichaelM, pubmed-author:FentonSteveS, pubmed-author:KeoghAnneA, pubmed-author:LeslieChristinaC, pubmed-author:MacdonaldPeterP, pubmed-author:RosenfeldtFranklinF, pubmed-author:ZhaoYi ChenYC
pubmed:issnType	Print
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	135-41
pubmed:year	2003
pubmed:articleTitle	Randomised double-blind, placebo-controlled trial of coenzyme Q, therapy in class II and III systolic heart failure.
pubmed:affiliation	Heart Failure Unit, St Vincent's Hospital, Sydney, Australia.
pubmed:publicationType	Journal Article